Showing 821 - 840 results of 102,530 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.09s Refine Results
  1. 821
  2. 822

    Processive receptor methylation compromises adaptation and decreases signaling noise. by William Pontius (460803)

    Published 2013
    “…Activities have been scaled and recentered with steady-state values at 0. (C) Increasing processivity also decreases the magnitude of fluctuations in <i>a</i>(<i>t</i>) in the adapted state around the mean value <i>a</i><sub>0</sub>. …”
  3. 823

    Damage accumulation decreases elongation rates and displaces growth equilibrium. by Audrey Menegaz Proenca (845486)

    Published 2019
    “…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”
  4. 824
  5. 825
  6. 826
  7. 827
  8. 828
  9. 829

    The expression of genes related to mitochondria was decreased in Pgam2 mice. by Junji Okuda (444322)

    Published 2013
    “…NRF-1: nuclear respiratory factor 1; CD36/FAT: CD36/fatty acid translocase; MCAD: medium-chain acyl coenzyme A dehydrogenase; Cox5a: mitochondrial cytochrome c oxidase subunit Va. …”
  10. 830

    CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

    Published 2014
    “…(C–D) Propidium Iodide cell cycle analysis revealed a decrease in percentage of cells in the G<sub>2</sub> phase in CXCL12-expressing cells compared to GFP controls. (*), (**), and (***) denote <i>P</i>≤0.05, <i>P</i>≤0.01, and <i>P</i>≤0.001 respectively in comparison to control cells (GFP). …”
  11. 831

    Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

    Published 2013
    “…Values are expressed as % of the mean of the responses recorded during 5 min before AVP application. …”
  12. 832
  13. 833
  14. 834

    SPL decreases diabetes-induced oxidative stress in GL and PT. by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…SPL treatment prevents diabetes-induced increment in O<sub>2</sub><sup>●―</sup> production (A) by using nicotinamide adenine dinucleotide phosphate (NADPH) as substrate and, diphenyleneiodonium (DPI) as inhibitor, lipid peroxidation (B) and protein carbonylation (C) and decreased GSH content (D) in GL (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s003" target="_blank">S3 Fig</a>). …”
  15. 835
  16. 836
  17. 837
  18. 838
  19. 839
  20. 840